[Principles and limitations in the use of protease inhibitors as antifibrinolytic agents].
D000595:Amino Acid Sequence; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D002417:Cattle; D005342:Fibrinolysis / Q000145:classification; D006801:Humans; D010195:Pancreatitis / Q000188:drug therapy; D010309:Parotitis / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000138:chemical synthesis; D010455:Peptides / Q000138:chemical synthesis; D011480:Protease Inhibitors; D011817:Rabbits
D000933:Antifibrinolytic Agents; D010455:Peptides; D011480:Protease Inhibitors; D010447:Peptide Hydrolases
Grundlagen und Grenzen der Anwendung von Proteaseninhibitoren als Antifibrinolytika.